The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection

By Atteno Mariangela   Costa Luisa   Matarese Alessandro   Caso Francesco   Puente Antonio   Cantarini Luca   Bocchino Maria   Sanduzzi Alessandro   Scarpa Raffaele  

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 543-547

Springer Publishing Company

Access to resources Recommend Favorite

Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy

By Iannone F   Fanizzi R   Scioscia C   Anelli MG   Lapadula G  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 41-44

Informa Healthcare

Access to resources Recommend Favorite

Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature

By Cuchacovich Raquel   Hagan Joseph   Khan Tahir   Richert Arthur   Espinoza Luis  

Clinical Rheumatology, Vol. 30, Iss. 1, 2011-01 ,pp. : 133-137

Springer Publishing Company

Access to resources Recommend Favorite

Adverse effects of methotrexate in three psoriatic arthritis patients

By Maejima Hideki   Watarai Akira   Nakano Toshiaki   Katayama Chieko   Nishiyama Hiromi   Katsuoka Kensei  

Rheumatology International, Vol. 34, Iss. 4, 2014-04 ,pp. : 571-574

Springer Publishing Company

Access to resources Recommend Favorite

A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis

By Pollono Eduardo   Lopez-Olivo Maria   Lopez Juan   Suarez-Almazor Maria  

Clinical Rheumatology, Vol. 29, Iss. 9, 2010-09 ,pp. : 947-955

Springer Publishing Company

Access to resources Recommend Favorite